Tailwinds point to better prospects for Emami; FY24 may see recovery in biz

While Emami is still struggling to push growth, given weak rural demand, the sale of the group’s stake in AMRI Hospitals should ease investor concerns about stake pledges by promoters. It has also carried a series of stake acquisitions which should enable the expansion of its brand portfolio.  

The Q2 results are likely to see flat volumes and low revenue growth alongside some gross margin expansion. The sale of AMRI has raised a value of Rs 2,300 crore, which will translate into Rs 1,100 crore to promoters, net of tax. This should enable the outstanding pledge of 33 per cent